The antibiotic minocycline has been suggested as a potential agent in cancer therapy due to its anti-inflammatory properties and effectiveness as an NF-ÎºB inhibitor.
In previous studies, we showed that minocycline could effectively block the fusion of breast epithelial cells and cancer cells.
However, its influence on breast cancer cell characteristics, including proliferation, migration, and gene expression has not yet been investigated.
